Female Health Co (FHCO) Files Form 4 Insider Buying : Michele Greco Buys 4,000 Shares

Female Health Co (FHCO): Michele Greco , CFO of Female Health Co purchased 4,000 shares on May 24, 2016. The Insider buying transaction was reported by the company on May 26, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.28 per share for a total value of $5,114.80 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 25, 2016, O B Parrish (CEO) purchased 10,000 shares at $1.29 per share price.On May 24, 2016, William R Jr Gargiulo (director) purchased 500 shares at $1.26 per share price.Also, On May 23, 2016, David R Bethune (director) purchased 100 shares at $1.26 per share price.On Dec 28, 2015, Andrew S Jr Love (director) purchased 25,000 shares at $1.45 per share price.

Female Health Co: On Wednesday, May 25, 2016 heightened volatility was witnessed in Female Health Co which led to swings in the share price. The shares opened for trading at $1.29 and hit $1.3318 on the upside , eventually ending the session at $1.32, with a gain of 2.56% or 0.033 points. The heightened volatility saw the trading volume jump to 98,060 shares. The 52-week high of the share price is $2.75 and the company has a market cap of $38 M . The 52-week low of the share price is at $1.16.

Female Health Co Money Flow Index Chart

The Female Health Company is a Female Condom company. The Company is engaged in manufacturing marketing and selling FC2 Female Condom (FC2). FC2 is used for both disease prevention and family planning the public health sector is the Company’s market. The Company operates in one industry segment which includes the development manufacture and marketing of consumer health care products. The FC2 product offered by the Company facilitates dual protection for women against both unintended pregnancy and STIs including HIV and AIDS its market encompasses both family planning and disease prevention. FC2’s primary usages are for disease prevention and family planning the public health sector is the Company’s main market. The Company markets products that prevent the transmission of HIV and AIDS through sexual intercourse: the male condom and FC2.

Leave a Reply

Female Health Co - Is it time to Sell?

Top Brokerage Firms are advising their investors on Female Health Co. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.